An Integrated Hypothesis That Considers Drusen as Biomarkers of Immune-Mediated Processes at the RPE-Bruch's Membrane Interface in Aging and Age-Related Macular Degeneration

https://doi.org/10.1016/S1350-9462(01)00010-6Get rights and content

Abstract

Age-related macular degeneration (AMD) is a blinding disease that afflicts millions of adults in the Western world. Although it has been proposed that a threshold event occurs during normal aging which leads to AMD, the sequelae of biochemical, cellular, and/or molecular events leading to the development of AMD are poorly understood. Although available data provide strong evidence that a significant proportion of AMD has a genetic basis, no gene(s) has yet been identified that causes a significant proportion of AMD. Moreover, no major molecular pathways involved in the etiology of this disease have been elucidated.

Drusen, pathological deposits that form between the retinal pigmented epithelium (RPE) and Bruch's membrane, are significant risk factors for the development of AMD. In our view, the development of testable new hypotheses of drusen origins has been hindered significantly by the absence of a comprehensive profile of their molecular composition. In this review, we describe an integrated ultrastructural, histochemical, molecular biological, and biochemical approach to identify specific molecular pathways associated with drusen biogenesis. The implicit assumption underlying these recent investigations has been that a thorough understanding of the composition of drusen and source(s) of drusen-associated material is likely to provide fresh insight into the pathobiology underlying AMD. Significantly, these studies have revealed that proteins associated with inflammation and immune-mediated processes are prevalent among drusen-associated constituents. Transcripts that encode a number of these molecules have been detected in retinal, RPE, and choroidal cells. These data have also lead to the observations that dendritic cells, potent antigen-presenting cells, are intimately associated with drusen development and that complement activation is a key pathway that is active both within drusen and along the RPE-choroid interface.

We propose herein a unifying hypothesis of drusen biogenesis that attempts to incorporate a large body of new and previously published structural, histochemical, and molecular data pertaining to drusen composition and development. This theory is put forth with the acknowledgment that numerous AMD genotypes may exist. Thus, only some aspects of the proposed hypothesis may be involved in any given AMD genotype. Importantly, this hypothesis invokes, for the first time, the potential for a direct role of cell- and immune-mediated processes in drusen biogenesis.

We acknowledge that the proposed hypothesis clearly represents a paradigm shift in our conceptualization pertaining to pathways that participate in the development of drusen and age-related macular degeneration. It is our hope that other investigators will test, validate and/or refute various aspects of this hypothesis, and in so doing, increase our overall understanding of the biological pathways associated with early AMD.

Section snippets

Drusen: an overview

Bruch's membrane (BM) lies at the boundary between the ocular retinal pigment epithelium (RPE) and the primary capillary bed of the choroid, the choriocapillaris (Coats, 1905; Hogan et al., 1971; Killingsworth, 1987). This stratified extracellular matrix is comprised of two collagen layers, referred to as the inner and outer collagenous layers, that flank a central domain comprised largely of elastin fibers and elastin-associated proteins. A number of excellent, comprehensive reviews pertaining

Recent progress on drusen composition

A number of studies have been undertaken in order to determine the composition of drusen over the last century and a half, due to the contention that understanding the composition of a disease-related deposit will provide new information about the disease process itself. Some of these studies are reviewed below.

Drusen biogenesis

It is almost certain that diverse biological processes are involved in the etiology of AMD. Any hypotheses that are advanced to explain the development of this disease must acknowledge that there may be more than one AMD genotype. Drusen formation, however, is a consistent feature of all AMD phenotypes and probably, all AMD genotypes. Indeed, the presence of small subclinical drusen is typically observed (both clinically and histologically in fellow eyes of donors where one eye exhibits clear

Recent developments in drusen biogenesis

Due to the lack of data pertaining to molecular composition, prior hypotheses of drusen biogenesis have relied almost exclusively upon morphologic observations and criteria. The addition of new compositional data, however, can now be used to formulate new hypotheses aimed at identifying the putative sequence of pathogenic events associated with drusen development.

Summary and future directions

Multiple, independent lines of investigation implicate a role for local inflammatory and immune-mediated events in the development of drusen and, by extension, in the etiology of AMD. These findings are particularly relevant in light of recent evidence that inflammation- and immune-associated pathways play significant roles in other degenerative diseases associated with advancing age (Akiyama et al., 2000; Glass and Witztum, 2001; Parums et al., 1990; Ross, 1999). In Alzheimer's disease and

Acknowledgements

We are extremely grateful to Drs. Natalia Aptsiauri, Markus Kuehn, Jose Sahel, Karen Gehrs, Alan Bird, Christina Frennesson, Michael Boulton, Usha Chakravarthy, Caroline Klaver, Steven Fliesler, Mimi Gross, Howard Lazarus, Marilyn Kincaid, Shiro Ozaki, Edwin Stone, and Stephen Russell for helpful comments and discussions over the years. We also gratefully acknowledge Kaj Anderson, Margie Kirchoff, Mary McDonald, Suzanna Zahn, Susan Shelton, Susan Shelton, Gregg Clark, Russ Warner, Jenna Kappel,

References (128)

  • C. Glass et al.

    Atherosclerosis. the road ahead

    Cell

    (2001)
  • W. Green et al.

    Age-related macular degeneration histopathologic studies

    Ophthalmology

    (1993)
  • W. Green et al.

    Pathologic features of senile macular degeneration

    Ophthalmol.

    (1985)
  • P. Hanutsaha et al.

    Indocyanine-green videoangiography of drusen as a possible predictive indicator of exudative maculopathy

    Ophthalmology

    (1998)
  • G. Holtkamp et al.

    Retinal pigment epithelium-immune system interactionscytokine production and cytokine-induced changes

    Prog. Retinal Eye Res.

    (2001)
  • F. Holz et al.

    Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors

    Ophthalmology

    (1994)
  • M. Ibrahim et al.

    The injured cellthe role of the dendritic cell system as a sentinel receptor pathway

    Immunol. Today

    (1995)
  • T. Ishibashi et al.

    Formation of drusen in the human eye

    Am. J. Ophthalmol.

    (1986)
  • L. Johnson et al.

    A potential role for immune complex pathogenesis in drusen formation

    Exp. Eye Res.

    (2000)
  • R. Klein et al.

    The Wisconsin age-related maculopathy grading system

    Ophthalmology

    (1991)
  • H. Lewis et al.

    Chorioretinal juncturemultiple extramacular drusen

    Ophthalmology

    (1986)
  • M. Matyszak et al.

    The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system

    Neuroscience

    (1996)
  • R. Mullins et al.

    Characterization of drusen-associated glycoconjugates

    Ophthalmology

    (1997)
  • D. Newsome et al.

    Detection of specific extracellular matrix molecules in drusen, Bruch's membrane, and ciliary body

    Am. J. Ophthalmol.

    (1987)
  • D. Pauleikhoff et al.

    Drusen as risk factors in age-related macular disease

    Am. J. Ophthalmol.

    (1990)
  • D. Pauleikhoff et al.

    Correlation between biochemical composition and fluorescein binding of deposits in Bruch's membrane

    Ophthalmology

    (1992)
  • P. Penfold et al.

    Immunological and aetiological aspects of macular degeneration

    Prog. Retinal Eye Res.

    (2001)
  • Macular Photocoagulation Study Group. (1993) Five-year follow-up of fellow eyes of patients with age-related macular...
  • Macular Photocoagulation Study Group. (1997) Risk factors for choroidal neovascularization in the second eye of...
  • J. Alexander et al.

    Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium

    Invest. Ophthalmol. Visual Sci.

    (1990)
  • A. Alt

    Contributions to the pathological anatomy of the human eye

    Arch. Ophthalmol. Otolaryngol.

    (1877)
  • D. Anderson et al.

    Vitronectin gene expression in the adult human retina

    Invest. Ophthalmol. Visual Sci.

    (1999)
  • R. Anderson et al.

    Free radicals and ocular disease

    Adv. Exp. Med. Biol.

    (1994)
  • R. Brem et al.

    Immunolocalization of integrins in the human retina

    Invest. Ophthalmol. Visual Sci.

    (1994)
  • N. Bressler et al.

    Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration

    Retina

    (1994)
  • N. Bressler et al.

    Drusen characteristics in patients with exudative versus non-exudative age-related macular degeneration

    Retina

    (1988)
  • N. Bressler et al.

    The grading and prevalence of macular degeneration in Chesapeake Bay watermen

    Arch. Ophthalmol.

    (1989)
  • R. Burns et al.

    Clinico-morphologic correlations of drusen of Bruch's membrane

    Trans. Am. Ophthalmol. Soc.

    (1980)
  • N. Chong et al.

    TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy

    Invest. Ophthalmol. Visual Sci.

    (2000)
  • Coats, G. (1905) The structure of the membrane of Bruch, and its relation to the formation of colloid excrescences....
  • C. Curcio et al.

    Accumulation of cholesterol with age in human Bruch's membrane

    Invest. Ophthalmol. Visual Sci.

    (2001)
  • C. Curcio et al.

    Basal linear deposit and large drusen are specific for age-related maculopathy

    Arch. Ophthalmol.

    (1999)
  • C. Curcio et al.

    The Alabama Age-Related Macular Degeneration Grading System for donor eyes

    Invest. Ophthalmol. Visual Sci.

    (1998)
  • Y. D’Souza et al.

    Ten year review of drusen-like lesions in mesangiocapillary glomerulonephritis—ii

    Invest. Ophthalmol. Visual Sci. (Suppl.)

    (2000)
  • K. Dastgheib et al.

    Granulomatous reaction to Bruch's membrane in age-related macular degeneration

    Arch. Ophthalmol.

    (1994)
  • F. Delori et al.

    Autofluorescence distribution associated with drusen in age-related macular degeneration

    Invest. Ophthalmol. Visual Sci.

    (2000)
  • F. Donders

    Beitrage zur pathologischen Anatomie des Auges

    Graefe's Arch. Clin. Exp. Ophthalmol.

    (1854)
  • S. Duke-Elder et al.
    (1967)
  • J. Dusek et al.

    Hereditary drusen of Bruch's membrane. IIstudies of semi-thin sections and electron microscopy results

    Klin Monatsbl Augenheilkd

    (1982)
  • J. Duvall-Young et al.

    Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusena histopathological report

    Br. J. Ophthalmol.

    (1989)
  • Cited by (1122)

    • Age-associated macular degeneration: Epidemiologic features, complications, and potential therapeutic approaches

      2024, Targeting Angiogenesis, Inflammation and Oxidative Stress in Chronic Diseases: Angiogenesis, Inflammation and Oxidative Stress in Chronic Diseases
    View all citing articles on Scopus

    Supported in part by grants NIH EY06463 (GSH), EY11515 (GSH), and EY11521 (DHA), The Ruth and Milton Steinbach Fund, Inc. (GSH), Ciba Vision/Novartis (GSH), a Research to Prevent Blindness Lew R. Wasserman Merit Award (GSH), The University of Iowa Center on Aging (AG00214; RM), and an unrestricted grant to the Department of Ophthalmology and Visual Sciences from Research to Prevent Blindness, Inc.

    View full text